American Optometric Association

 Southern California College of Optometry Celebrates 120 Years of Educational and Clinical Excellence

Retrieved on: 
Wednesday, April 3, 2024
Education, Health, Research, Science, University, Optical, Psychiatry, MBKU, Longevity, Accreditation Council, Specialization, Learning, Mentorship, Marshall B. Ketchum University, American Optometric Association, American Academy, Faculty, SCCO, Student, Publication, Vision science, Pharmacy, Pathology, Multimedia, AOA, OD, Accreditation, Ophthalmology, Nursing

Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution headquartered in Fullerton, Calif. proudly celebrates the 120th anniversary of its Southern California College of Optometry (SCCO) .

Key Points: 
  • Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution headquartered in Fullerton, Calif. proudly celebrates the 120th anniversary of its Southern California College of Optometry (SCCO) .
  • Since then, it has earned a reputation as one of the oldest and most esteemed optometry schools in the nation.
  • View the full release here: https://www.businesswire.com/news/home/20240403689163/en/
    Southern California College of Optometry Celebrates 120 Years (Graphic: Business Wire)
    "SCCO's 120-year journey signifies more than just longevity; it represents a commitment to best-in-class optometric education,” said Dr. Julie A. Schornack, president at MBKU.
  • As SCCO celebrates its 120-year legacy, it remains steadfast in its commitment to cultivating the leaders of tomorrow.

Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States

Retrieved on: 
Monday, April 1, 2024
Glaucoma, Agonist, Rheumatoid arthritis, Phenylephrine, Diabetes, Inflammation, Patient, Ageing, American Optometric Association, Eye injury, American Academy, Mydriasis, United, Viatris, Eye, Parasympatholytic, Uveitis, Lens, Pupil, Tropicamide, FDA, Cataract, Diabetic retinopathy, Food, Pharmaceutical industry

PITTSBURGH, April 1, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the U.S. commercial launch of RYZUMVI™ (phentolamine ophthalmic solution) 0.75% for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents in the United States.

Key Points: 
  • PITTSBURGH, April 1, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the U.S. commercial launch of RYZUMVI™ (phentolamine ophthalmic solution) 0.75% for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents in the United States.
  • The onset of action of RYZUMVI generally occurs in 30 minutes.
  • In the MIRA-2 trials' placebo group, 34% of patients were still dilated (had not returned to ≤ 0.2 mm of baseline pupil diameter) at 24 hours.
  • To avoid the potential for eye injury or contamination, care should be taken to avoid touching the vial tip to the eye or to any other surface.

Advancing Clinical Excellence: 20/20 Onsite Life Sciences Clinic Managers Achieve Prestigious Certified Paraoptometric Status

Retrieved on: 
Wednesday, February 14, 2024
Optical, Health, Clinical Trials, Ophthalmology, Certification, Education, CPO, CONFIG.SYS, AOA, Doctor, Patient, Knowledge, American Optometric Association, Nursing

20/20 Onsite, a leader in innovative mobile clinical vision solutions, proudly announces that all of its Life Sciences clinic managers are now Certified Paraoptometrics (CPOs) after a stringent examination process.

Key Points: 
  • 20/20 Onsite, a leader in innovative mobile clinical vision solutions, proudly announces that all of its Life Sciences clinic managers are now Certified Paraoptometrics (CPOs) after a stringent examination process.
  • The Certified Paraoptometric (CPO) designation is a national certification awarded to individuals who have demonstrated a comprehensive understanding of the concepts and practices utilized in optometric care.
  • Achieving CPO status signifies that 20/20 Onsite’s Life Sciences clinic managers have demonstrated an in-depth understanding of various subject areas within optometry and have committed to upholding the highest standards of care in the eye care industry.
  • “With this deeper scope of practice, our certified clinic managers can further alleviate the barriers to staffing that so often delay or derail ophthalmology assessments on clinical trials.”

Visibly Launches Real-Time Video Consultations Through Merger With EyecareLive

Retrieved on: 
Thursday, January 18, 2024
Patient, Eye, Partnership, American Optometric Association, FDA, Telehealth, Retail

CHICAGO, Jan. 18, 2024 /PRNewswire/ -- Visibly , a leading healthcare technology company, is thrilled to announce the merger of Visibly and EyecareLive .

Key Points: 
  • CHICAGO, Jan. 18, 2024 /PRNewswire/ -- Visibly , a leading healthcare technology company, is thrilled to announce the merger of Visibly and EyecareLive .
  • In collaboration with EyecareLive, Visibly will launch real-time video visits between optometrists and patients, allowing for more comprehensive vision consultations.
  • EyecareLive also brings technology to Visibly allowing remote comprehensive eye exams to supplement care when a doctor is not available to increase accessibility and care options.
  • The EyecareLive platform includes eye health monitoring tools, real-time video visits, HIPAA-compliant messaging, virtual testing, and built-in e-prescribe and e-commerce functionality.

iVeena Awarded NEI-SBIR Grant For Progressive Myopia Drug Candidate IVMED-85

Retrieved on: 
Thursday, October 26, 2023
Health, Clinical Trials, Research, Science, Pharmaceutical, Optical, Biotechnology, IND, American Optometric Association, NEI, National Eye Institute, Glaucoma, SBIR, Research and development, Near-sightedness, Doctor of Philosophy, Risk, Retinal detachment, Cornea, Medicinal chemistry, University, Eye, NIH, Cataract

iVeena Delivery Systems Inc. (“iVeena”) , a biopharmaceutical company with a developmental product in pediatric myopia is pleased to announce that Dr. Sarah Molokhia, Vice President of Research & Development for iVeena and Adjunct Assistant Professor at Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah, was awarded a National Eye Institute Phase 1 Small Business Innovative Research (SBIR) grant of $345,000 for iVeena’s progressive myopia control drug candidate IVMED-85.

Key Points: 
  • iVeena Delivery Systems Inc. (“iVeena”) , a biopharmaceutical company with a developmental product in pediatric myopia is pleased to announce that Dr. Sarah Molokhia, Vice President of Research & Development for iVeena and Adjunct Assistant Professor at Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah, was awarded a National Eye Institute Phase 1 Small Business Innovative Research (SBIR) grant of $345,000 for iVeena’s progressive myopia control drug candidate IVMED-85.
  • Myopia generally first occurs in school-age children and progresses as the eye grows.
  • IVMED-85 is an experimental topical eye drop that is designed to be administered twice-daily to slow the progression of myopia in children.
  • Dr. Molokhia added that “The NIH and NEI have been extremely supportive of our topical eye drop for treatment of progressive myopia.

SightMD Welcomes Taylor Rado, OD to its expert team in New York

Retrieved on: 
Monday, October 2, 2023
Contact, Glaucoma, New England, American Optometric Association, Surgeon, Macular degeneration, Friends, OD, New England College, New England College of Optometry, Patient, Woodbury, Diabetic retinopathy, Union College, Family, Commerce, Nursing, Neuroscience, Optometry, Growth

HAUPPAUGE, N.Y., Oct. 2, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Taylor Rado, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Taylor Rado, OD to its expert team.
  • HAUPPAUGE, N.Y., Oct. 2, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Taylor Rado, OD to its expert team.
  • Dr. Taylor Rado is a board certified optometrist who enjoys providing comprehensive eye care, fitting contact lenses, and managing post-op care in collaboration with the other providers at SightMD.
  • She then went on to complete her Doctor of Optometry degree at the New England College of Optometry in Boston, Massachusetts.

OmniActive Health Technologies Promotes Importance of Children's Eye and Brain Health with Its "Lutein for Every Age" Initiative

Retrieved on: 
Tuesday, September 12, 2023
Learning, American Optometric Association, Mineral, CDN, Life, OD, Parent, Eye, American Academy, American Academy of Ophthalmology, OnePoll, Research, Vegetable, Lutein, Salmon, Vitamin, Achievement Medal, Child, Knowledge, Mental health, Memory, Caregiver, Toy, Ophthalmology

For most, this means arranging tutors, scheduling doctor's appointments, and encouraging participation in extracurricular activities to maximize children's learning potential.

Key Points: 
  • For most, this means arranging tutors, scheduling doctor's appointments, and encouraging participation in extracurricular activities to maximize children's learning potential.
  • For example, parents rank milk, apples, and salmon as the top three items they serve their child for eye health.
  • Unfortunately, parents perceive carrots as the best fruit/vegetable for eye health (15%) when kale and pumpkin are better.
  • This random double-opt-in survey of 2,000 parents with school-age kids (ages 5–18) was commissioned by OmniActive Health Technologies between Aug. 25 and Aug. 29, 2023.

Pinakin Davey, OD, PhD, FAAO, FARVO, Joins EyePromise® as Chief Medical & Science Officer

Retrieved on: 
Thursday, June 22, 2023
Health, Fitness & Nutrition, Other Science, Research, Science, Vitamins, Supplements, Optical, OGS, Glaucoma, American Optometric Association, ARVO, University, AAO, Macular degeneration, Doctor of Philosophy, Australian College of Optometry, Western University, Southern College of Optometry, AOA, Anglia Ruskin University, Patient, American Academy of Optometry, Outline of health sciences, Association for Research in Vision and Ophthalmology, University of Louisville School of Medicine, ZX, Western University of Health Sciences, Nursing, Optometry, Ophthalmology

EyePromise, the leading provider of evidence-based nutritional supplements for eye health, is pleased to announce the appointment of Dr. Pinakin Davey as its new Chief Medical & Science Officer.

Key Points: 
  • EyePromise, the leading provider of evidence-based nutritional supplements for eye health, is pleased to announce the appointment of Dr. Pinakin Davey as its new Chief Medical & Science Officer.
  • As the Chief Medical & Science Officer, Dr. Davey will play a pivotal role in shaping and driving EyePromise’s scientific and medical initiatives.
  • Dr. Pinakin Davey will also remain in his current position as a tenured Professor at Western University of Health Sciences, College of Optometry.
  • "We are thrilled to welcome Dr. Davey to EyePromise as our Chief Medical & Science Officer," said Andreas Wolf, President of EyePromise.

THE AMERICAN OPTOMETRIC ASSOCIATION LAUNCHES FIRST EVER EYE-FRIENDLY MOBILE BOARD GAME, BLINK LAND

Retrieved on: 
Thursday, June 15, 2023
Infection, American Optometric Association, Partnership, Headache, Google Play, Eye, Blinking, AOA, Risk, Health, Screen time, Personal protective equipment, Casino, Video game, Optometry

ST. LOUIS, June 15, 2023 /PRNewswire/ -- Today, the American Optometric Association (AOA), the leading authority on quality eye care and an advocate for our nation's health, launched Blink Land, a single-player mobile game that teaches players about eye health and its relation to screen time.

Key Points: 
  • Prolonged screen time also can increase your risk of developing eye infections due to decreased blink rate while viewing screens.
  • Blinking spreads tears across the eye, and when eyes don't have enough tears to rinse away foreign matter, they become more prone to infection.
  • To solve for this, Blink Land will educate gamers how screen time and eye health are connected through minigames, facts, and trivia throughout the game.
  • Blink Land provides gamers with the opportunity to learn about eye health and adopt healthy eye habits alongside the hero character "Blink."

SightMD Welcomes The Ophthalmic Center To Its Expert Team

Retrieved on: 
Tuesday, March 28, 2023
Doctor of Medicine, Molecular biology, Contact, Glaucoma, Vincent, Harry S. Truman Memorial Veterans' Hospital, American Optometric Association, Miller Place, New York, Partnership, Refractive surgery, Macular degeneration, Education, S4, Doctor of Philosophy, Life, OD, Refraction, Cataract, University School, Bachelor of Arts, Optometry, Ophthalmology, Quality of life, Ward Melville High School, New York Medical College, University of St Andrews, Eye, Research, Washington University in St. Louis, Three Villages, Patient, New York University Grossman School of Medicine, United Kingdom, Hofstra University, IOL, Captain James A. Lovell Federal Health Care Center, Nursing, LASIK, New York University, MD

HAUPPAUGE, N.Y., March 28, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform, today announced a strategic partnership with The Ophthalmic Center (TOC Eye), an eastern Long Island based ophthalmology practice. Through this strategic partnership the practices in East Setauket, 8 Technology Drive East Setauket, NY 11733 and in Wading River, 6144 Route 25A Wading River, NY 11792 will expand SightMD's presence by adding two location and four providers, growing SightMD's current footprint to 40+ locations and 85+ providers across New York.

Key Points: 
  • HAUPPAUGE, N.Y., March 28, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform, today announced a strategic partnership with The Ophthalmic Center (TOC Eye), an eastern Long Island based ophthalmology practice.
  • Thousands of people have trusted their award-winning team with their families' eye care and vision correction treatment, and we are grateful for the opportunity to have them join the expert team at SightMD.
  • The doctors at TOC Eye joining the SightMD team are Vincent P. Basilice, MD, Michael Conners, MD, Alexander Llinas, MD, and Alex Schaffer, OD.
  • Jeffrey Martin, MD, Co-founder and President of SightMD, said, "I am honored to be partnering with the eye doctors of The Ophthalmic Center.